Comparable: structured measurement intended for within-endpoint comparison when assay context matches
Assay / model
AUC last in human patient with relapsed solid tumor at 20 mg/m'2, iv administered on days 1, 2, 8, 9, 15 and 16 of 28-day cycle over 2 to 10 mins measured on day 1 of cycle 1 by LC-MS/MS analysis · human
Condition
Route: iv · area under curve · AUC · CHEMBL3533274 · CHEMBL372 · CHEMBL3526139 · CHEMBL451887 · AUC last in human patient with relapsed solid tumor at 20 mg/m'2, iv administered on days 1, 2,...
